Concerto Biosciences, Inc. — Form D/A
Concerto Biosciences, Inc. of ALLSTON, MA, a company, filed a Form D amendment with the SEC on 2022-06-16. The offering totals $24.5M, of which $24.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-16
- Form: D/A
- Accession: 0001918491-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.5M
- Amount sold: $24.5M
- Investors: 37
- Date of first sale: 2022-03-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438545
Issuer
- Name: Concerto Biosciences, Inc.
- CIK: 0001918491
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 127 WESTERN AVE, ALLSTON, MA, 02134
- Phone: 617-544-7044
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Cheri Ackerman | Director | Allston, MA |
| Bernardo Cervantes | Director | Allston, MA |
| Jared Kehe | Director | Allston, MA |
| Sarah Luppino | Director | Allston, MA |
| Vera Schroeder | Director | LONG ISLAND CITY, NY |
| Cheri Ackerman | Executive Officer | Allston, MA |
| Bernardo Cervantes | Executive Officer | Allston, MA |
| Jared Kehe | Executive Officer | Allston, MA |
Other filings by this issuer (1)
More